321 related articles for article (PubMed ID: 35178898)
41. Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia?
Williams GR; Deal AM; Muss HB; Weinberg MS; Sanoff HK; Nyrop KA; Pergolotti M; Shachar SS
Oncotarget; 2017 May; 8(20):33658-33665. PubMed ID: 28431396
[TBL] [Abstract][Full Text] [Related]
42. Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer.
Park IK; Yang SS; Chung E; Cho ES; Lee HS; Shin SJ; Im YC; Park EJ; Baik SH; Lee KY; Kang J
Cancer Med; 2021 Dec; 10(23):8451-8461. PubMed ID: 34643052
[TBL] [Abstract][Full Text] [Related]
43. Opportunistic muscle measurements on staging chest CT for extremity and truncal soft tissue sarcoma are associated with survival.
Phan EN; Thorpe SW; Wong FS; Saiz AM; Taylor SL; Canter RJ; Lenchik L; Randall RL; Boutin RD
J Surg Oncol; 2020 Oct; 122(5):869-876. PubMed ID: 32613648
[TBL] [Abstract][Full Text] [Related]
44. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ
Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293
[TBL] [Abstract][Full Text] [Related]
45. Automated Muscle Measurement on Chest CT Predicts All-Cause Mortality in Older Adults From the National Lung Screening Trial.
Lenchik L; Barnard R; Boutin RD; Kritchevsky SB; Chen H; Tan J; Cawthon PM; Weaver AA; Hsu FC
J Gerontol A Biol Sci Med Sci; 2021 Jan; 76(2):277-285. PubMed ID: 32504466
[TBL] [Abstract][Full Text] [Related]
46. Myosteatosis predicts short-term mortality in patients with COVID-19: A multicenter analysis.
Surov A; Meyer HJ; Ehrengut C; Zimmermann S; Schramm D; Hinnerichs M; Bär C; Borggrefe J
Nutrition; 2024 Apr; 120():112327. PubMed ID: 38341908
[TBL] [Abstract][Full Text] [Related]
47. Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery.
Xiao J; Caan BJ; Cespedes Feliciano EM; Meyerhardt JA; Peng PD; Baracos VE; Lee VS; Ely S; Gologorsky RC; Weltzien E; Kroenke CH; Kwan ML; Alexeeff SE; Castillo AL; Prado CM
JAMA Surg; 2020 Oct; 155(10):942-949. PubMed ID: 32805015
[TBL] [Abstract][Full Text] [Related]
48. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
[TBL] [Abstract][Full Text] [Related]
49. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
50. Validation for measurements of skeletal muscle areas using low-dose chest computed tomography.
Lim WH; Park CM
Sci Rep; 2022 Jan; 12(1):463. PubMed ID: 35013501
[TBL] [Abstract][Full Text] [Related]
51. Sarcopenia and Skeletal Muscle Quality as Predictors of Postoperative Complication and Early Mortality in Gynecologic Cancer.
Silva de Paula N; de Aguiar Bruno K; Azevedo Aredes M; Villaça Chaves G
Int J Gynecol Cancer; 2018 Feb; 28(2):412-420. PubMed ID: 29266018
[TBL] [Abstract][Full Text] [Related]
52. Low skeletal muscle mass defined by thoracic CT as a prognostic marker in acute pulmonary embolism.
Meyer HJ; Benkert F; Bailis N; Lerche M; Denecke T; Surov A
Nutrition; 2022 Jun; 98():111622. PubMed ID: 35436690
[TBL] [Abstract][Full Text] [Related]
53. Skeletal Muscle Quality Beyond Average Muscle Attenuation: A Proposal of Skeletal Muscle Phenotypes to Predict Short-Term Survival in Patients With Endometrial Cancer.
Rodrigues CS; Chaves GV
J Natl Compr Canc Netw; 2018 Feb; 16(2):153-160. PubMed ID: 29439176
[No Abstract] [Full Text] [Related]
54. Age-related changes in muscle quality and development of diagnostic cutoff points for myosteatosis in lumbar skeletal muscles measured by CT scan.
Kim HK; Kim KW; Kim EH; Lee MJ; Bae SJ; Ko Y; Park T; Shin Y; Kim YJ; Choe J
Clin Nutr; 2021 Jun; 40(6):4022-4028. PubMed ID: 34144412
[TBL] [Abstract][Full Text] [Related]
55. Peripheral but not axial muscle mass is associated with early mortality in bone metastatic lung cancer patients at diagnosis.
Dandache C; Confavreux CB; Gavoille A; Massy E; Chambard L; Rambaud J; Geye M; Brevet M; Girard N; Subtil F; Pialat JB
Joint Bone Spine; 2023 Sep; 90(5):105613. PubMed ID: 37442335
[TBL] [Abstract][Full Text] [Related]
56. Factors associated with variability in skeletal muscle radiodensity in patients with metastatic cancer.
Calixto-Lima L; Wiegert EVM; de Oliveira LC; Chaves GV; Avesani CM; Bezerra FF
Nutrition; 2024 Apr; 120():112351. PubMed ID: 38330891
[TBL] [Abstract][Full Text] [Related]
57. Relationship between nonalcoholic fatty liver disease and muscle quality as well as quantity evaluated by computed tomography.
Tanaka M; Okada H; Hashimoto Y; Kumagai M; Nishimura H; Oda Y; Fukui M
Liver Int; 2020 Jan; 40(1):120-130. PubMed ID: 31518481
[TBL] [Abstract][Full Text] [Related]
58. The association between geriatric assessment, muscle measures, and treatment-related toxicity in older adults with cancer: An Israeli prospective study.
Shachar SS; Bar-Sela G; Peer A; Moskovitz MT; Bareket-Samish A; Epstein J; Wollner M; Shafran I; Boukal A; Williams GR
J Geriatr Oncol; 2022 Nov; 13(8):1203-1207. PubMed ID: 35989184
[TBL] [Abstract][Full Text] [Related]
59. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation.
Kuo SZ; Ahmad M; Dunn MA; Montano-Loza AJ; Carey EJ; Lin S; Moghe A; Chen HW; Ebadi M; Lai JC
Transplantation; 2019 Nov; 103(11):2312-2317. PubMed ID: 30985575
[TBL] [Abstract][Full Text] [Related]
60. Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
Roberti E; Merlano M; Ravanelli M; Alberti A; Esposito A; Gili R; Spinazzé S; Baré C; Jocollé G; Benasso M; Bertolotti F; Vecchio S; Bacigalupo A; Licitra L; Denaro N; Damico M; Lorini L; Gurizzan C; Alfieri S; Bossi P
Oral Oncol; 2023 Oct; 145():106540. PubMed ID: 37567147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
